Table 3.
Antibacterial Drug | 2018 n (R)% | 2019 n (R)% | 2020 n (R)% | 2018–2020 n (R)% |
---|---|---|---|---|
n = 70 | n = 91 | n = 95 | n = 256 | |
Piperacillin/tazobactam | 42 (60.0) | 51 (56.0) | 48 (50.5) | 141 (55.1) |
Ceftazidime | 44 (62.9) | 61 (67) | 51 (53.1) | 156 (60.9) |
Cefepime | 44 (62.9) | 52 (57.1) | 48 (50.0) | 144 (56.3) |
Imipenem | 34 (48.5) | 43 (47.3) | 40 (42.1) | 117 (45.7) |
Bactrim | 39 (55.7) | 48 (52.7) | 48 (50.0) | 135 (52.7) |
Ciprofloxacin | 47 (67.1) | 64 (70.3) | 60 (62.5) | 171 (66.8) |
Gentamicin | 42 (60.0) | 57 (62.6) | 59 (61.5) | 158 (61.7) |
Tobramycin | 33 (47.1) | 51 (56.0) | 50 (52.1) | 134 (52.3) |
Ampicillin/Sulbactam | 49 (70) | 66 (72.5) | 63 (65.6) | 178 (69.5) |
Levofloxacin | 44 (62.9) | 63 (69.2) | 57 (59.4) | 164 (64.1) |
Nitrofurantoin | 40 (57.1) | 53 (58.2) | 55 (57.3) | 148 (57.8) |
Ampicillin | 52 (74.3) | – | – | – |
Amikacin | 25 (35.7) | 35 (38.5) | 33 (34.4) | 93 (36.3) |
Ceftriaxone | 50 (71.4) | 67 (73.6) | 61 (63.5) | 178 (69.5) |
Cefotetan | 31 (44.3) | 42 (46.2) | 45 (46.9) | 118 (46.1) |
Ertapenem | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Abbreviations: n, number of strains; R, drug resistance rate; “-”, Not detected.